Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.11B |
| 2 |
Snowflake
SNOW
|
+$1.67B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.61B |
| 4 |
Shopify
SHOP
|
+$1.42B |
| 5 |
Royalty Pharma
RPRX
|
+$1.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$2.27B |
| 2 |
Amazon
AMZN
|
+$2.09B |
| 3 |
Vipshop
VIPS
|
+$1.28B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.27B |
| 5 |
Alibaba
BABA
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Healthcare | 9.78% |
| 3 | Financials | 9.01% |
| 4 | Communication Services | 8.96% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Verra Mobility
VRRM
$717M
| $6.51M | ﹤0.01% |
481,002
-520,936
| -52% | -$7.22M |
|
|
EGRX
3102
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $6.5M | ﹤0.01% |
155,733
-28,192
| -15% | -$1.31M |
|
|
GCP
3103
DELISTED
GCP Applied Technologies Inc.
GCP
| $6.5M | ﹤0.01% |
264,829
+86,741
| +49% | +$2.2M |
|
3104
Pinnacle Financial Partners Inc
PNFP
$16.3B
| $6.49M | ﹤0.01% |
73,215
-27,878
| -28% | -$2.21M |
|
|
YMAB
3105
DELISTED
Y-mAbs Therapeutics
YMAB
| $6.48M | ﹤0.01% |
214,436
+82,151
| +62% | +$3.37M |
|
3106
Blue Bird Corp
BLBD
$2.05B
| $6.46M | ﹤0.01% |
258,215
+203,545
| +372% | +$4.64M |
|
|
SBBP
3107
DELISTED
Strongbridge Biopharma plc.
SBBP
| $6.43M | ﹤0.01% |
2,329,880
+376,782
| +19% | +$1.14M |
|
3108
Carpenter Technology
CRS
$27.1B
| $6.42M | ﹤0.01% |
156,119
-78,254
| -33% | -$2.97M |
|
3109
iShares Russell Top 200 Value ETF
IWX
$4.04B
| $6.42M | ﹤0.01% |
100,737
+22,875
| +29% | +$1.39M |
|
3110
Adeia
ADEA
$3.29B
| $6.41M | ﹤0.01% |
1,112,012
-445,877
| -29% | -$2.57M |
|
3111
TTEC Holdings
TTEC
$77.9M
| $6.4M | ﹤0.01% |
63,751
-17,792
| -22% | -$1.51M |
|
|
CMIIU
3112
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
| $6.4M | ﹤0.01% |
+500,252
| New | +$6.28M |
|
3113
Albany International
AIN
$1.84B
| $6.39M | ﹤0.01% |
76,513
-19,580
| -20% | -$1.55M |
|
|
NPKI
3114
NPK International
NPKI
$1.21B
| $6.39M | ﹤0.01% |
2,033,852
+1,903,527
| +1,461% | +$5.87M |
|
|
DVAX
3115
DELISTED
Dynavax Technologies
DVAX
| $6.37M | ﹤0.01% |
648,233
+195,304
| +43% | +$1.61M |
|
|
SAFE
3116
DELISTED
Safehold Inc.
SAFE
| $6.37M | ﹤0.01% |
90,904
-3,631
| -4% | -$274K |
|
|
AWP
3117
abrdn Global Premier Properties Fund
AWP
$366M
| $6.36M | ﹤0.01% |
356,435
-4,032
| -1% | -$66.7K |
|
|
SAFE
3118
Safehold
SAFE
$1.08B
| $6.36M | ﹤0.01% |
73,503
-55,808
| -43% | -$4.48M |
|
3119
Innospec
IOSP
$2.31B
| $6.36M | ﹤0.01% |
61,934
-17,195
| -22% | -$1.7M |
|
3120
ITT
ITT
$19.6B
| $6.36M | ﹤0.01% |
69,899
-18,195
| -21% | -$1.5M |
|
|
EDD
3121
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$372M
| $6.35M | ﹤0.01% |
1,054,906
+243,855
| +30% | +$1.49M |
|
|
LTC
3122
LTC Properties
LTC
$2.17B
| $6.35M | ﹤0.01% |
152,172
-27,551
| -15% | -$1.14M |
|
3123
America's Car Mart
CRMT
$25.7M
| $6.34M | ﹤0.01% |
41,645
+309
| +0.7% | +$41.9K |
|
3124
Viasat
VSAT
$11.4B
| $6.33M | ﹤0.01% |
131,798
-112,357
| -46% | -$5.44M |
|
3125
Cerus
CERS
$601M
| $6.33M | ﹤0.01% |
1,053,927
-322,187
| -23% | -$2.19M |
|
Similar funds
Morgan Stanley's Q1 2021 Portfolio in Review
As of Q1 2021, Morgan Stanley held 7,749 positions worth $681B, up 5.1% from $647B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q1 2021 filing shows 618 new, 3,173 increased, 3,213 reduced and 189 closed positions. Its largest new stake was Coupang: 16,573,913 shares worth $818M. The largest sale was Paramount Global Class B, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2021 buy was Coupang: 16,573,913 shares worth $818M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $3.11B increase.
- Morgan Stanley's biggest Q1 2021 reduction was Paramount Global Class B, cutting an estimated $2.27B.
- Morgan Stanley fully exited Tiffany & Co. in Q1 2021, selling an estimated $318M.
- Morgan Stanley's ten largest holdings make up 16% of its $681B portfolio in Q1 2021.
- Morgan Stanley opened 618 new positions and closed 189 in Q1 2021.
- Morgan Stanley's portfolio value rose 5.1% quarter-over-quarter to $681B.
Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.